A detailed history of Hanson & Doremus Investment Management transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 1,036 shares of TMO stock, worth $552,208. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,036
Previous 1,036 -0.0%
Holding current value
$552,208
Previous $572,000 11.89%
% of portfolio
0.1%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$541.52 - $599.02 $83,935 - $92,848
155 Added 17.59%
1,036 $572,000
Q1 2024

Apr 22, 2024

SELL
$528.82 - $599.43 $18,508 - $20,980
-35 Reduced 3.82%
881 $512,000
Q3 2023

Oct 24, 2023

BUY
$498.29 - $574.41 $39,863 - $45,952
80 Added 9.57%
916 $463,000
Q2 2023

Jul 18, 2023

SELL
$508.46 - $591.13 $18,813 - $21,871
-37 Reduced 4.24%
836 $436,000
Q4 2022

Jan 18, 2023

BUY
$484.71 - $571.37 $8,724 - $10,284
18 Added 2.11%
873 $481,000
Q3 2022

Oct 20, 2022

SELL
$507.19 - $604.49 $90,279 - $107,599
-178 Reduced 17.23%
855 $434,000
Q1 2022

Apr 22, 2022

BUY
$524.0 - $644.92 $52,400 - $64,491
100 Added 10.72%
1,033 $610,000
Q3 2021

Oct 21, 2021

BUY
$509.53 - $609.78 $296,546 - $354,891
582 Added 165.81%
933 $533,000
Q2 2021

Jul 22, 2021

BUY
$441.0 - $508.24 $5,733 - $6,607
13 Added 3.85%
351 $155,000
Q4 2020

Feb 01, 2021

SELL
$435.06 - $527.66 $5,655 - $6,859
-13 Reduced 3.7%
338 $157,000
Q4 2019

Jan 16, 2020

SELL
$271.93 - $328.04 $7,885 - $9,513
-29 Reduced 7.63%
351 $114,000
Q2 2018

Aug 08, 2018

BUY
$203.14 - $219.53 $16,251 - $17,562
80 Added 26.67%
380 $62,000
Q4 2017

Jan 25, 2018

BUY
$182.03 - $200.37 $54,609 - $60,111
300
300 $57,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $209B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.